EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate

Amélie E Bura, Andrea Rolong, Christophe Paget, Maxime Guéguinou

Trends in Immunology · 2026-06

DOI: 10.1016/j.it.2026.05.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-06. Verfasst von Amélie E Bura und 3 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France. Die Arbeit nennt 121 Literaturangaben. Gefördert von: Le Studium Loire Valley-Institute for Advanced Studies, Region Centre-Val de Loire, Cancéropôle du Grand Ouest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial calcium (mtCa2+) has long been framed as a bioenergetic regulator, yet evidence redefines it as a relevant immunometabolic switch. Within the tumor microenvironment, the mitochondrial calcium uniporter (MCU) complex and the NCLX-TMEM65 efflux axis maintain a 'Goldilocks zone' of Ca2+ homeostasis. This can be exploited by cancer cells to sustain oxidative phosphorylation and tricarboxylic acid-derived oncometabolite production, including succinate, fumarate, and 2-hydroxyglutarate, while imposing ionic and nutrient constraints on infiltrating immune cells. Chronic mtCa2+ overload in effector T cells drives mitochondrial dysfunction and exhaustion, while oxidative phosphorylation-dependent Ca2+ flux enforces the acquisition of an immunosuppressive profile in macrophages. Disrupting these tumor-immune ionic imbalances through selective MCU modulation or efflux pathway targeting offers a strategy to restore immune surveillance and/or enhance immune checkpoint inhibitor therapies.

Schlagwörter

Stichwörter der Autor:innen

T cellscancerimmune checkpoint blockadeimmunometabolismmitochondrial calcium signalingtumor-associated macrophages

Autor:innen und Institutionen

  • INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France.
  • INSERM UMR1100 CEPR Centre d'Etude Des Pathologies Respiratoires, Tours, France.
  • INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France. Electronic address: maxime.gueguinou@univ-tours.fr.

Förderung

  • Le Studium Loire Valley-Institute for Advanced Studies
  • Region Centre-Val de Loire
  • Cancéropôle du Grand Ouest
  • National League Against Cancer
  • Fondation ARC pour la Recherche sur Le Cancer

Zitieren

APA

Bura, A. E., Rolong, A., Paget, C., & Guéguinou, M. (2026). Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate. Trends in Immunology. https://doi.org/10.1016/j.it.2026.05.012

Vancouver

Bura AE, Rolong A, Paget C, Guéguinou M. Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate. Trends in Immunology. 2026. doi:10.1016/j.it.2026.05.012

BibTeX
@article{Bura2026,
  author = {Bura, Amélie E and Rolong, Andrea and Paget, Christophe and Guéguinou, Maxime},
  title = {Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate},
  journal = {Trends in Immunology},
  year = {2026},
  doi = {10.1016/j.it.2026.05.012}
}
Kostenlos starten →